Ottar N. Bjornstad | USGS Science

USGS2021

Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making

More than 1.6 million Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) tests were administered daily in the United States at the peak of the epidemic, with a significant focus on individual treatment. Here, we show that objective-driven, strategic sampling designs and analyses can maximize information gain at the population level, which is necessary to increase situational awareness and predict, prepare for, and respond to a pandemic, while also continuing to inform individual treatment. By focusing on specific objectives such as individual treatment or disease prediction and control (e.g., via the collection of population-level statistics to inform lockdown measures or vaccine rollout) and drawing from the literature on capture–recapture methods to deal with nonrandom sampling and testing errors, we illustrate how public health objectives can be achieved even with limited test availability when testing programs are designed a priori to meet those objectives.

PLoS Biology↗

USGS2019

Concurrent assessment of epidemiological and operational uncertainties for optimal outbreak control: Ebola as a case study

Determining how to best manage an epidemiological outbreak may be hindered by both epidemiological uncertainty (i.e. about epidemiological processes) and operational uncertainty (i.e. about the effectiveness of candidate interventions). These two uncertainties are rarely addressed concurrently in epidemic studies, impeding decision-making. We present an approach to simultaneously address both sources of uncertainty. Epidemiological uncertainty is represented by a large ensemble of models of the 2014 West African Ebola outbreak. Operational uncertainty about the effectiveness of three classes of intervention is assessed for a wide range of potential effectiveness for each intervention. We ranked each intervention in terms of caseload reduction in each model, initially assuming an unlimited budget. To explore the role of budget limitation, we assessed the influence of three candidate cost functions relating intervention effectiveness and cost for different budget levels. The Value of Information (VoI) to resolve uncertainty is generally high in this study; appropriate information gain could reduce expected caseload by more than 50%. The ranking of interventions is jointly determined by the underlying epidemiological process, the effectiveness of the interventions and the size of the budget available for the program. An epidemiologically effective intervention might not be optimal if its costs outweigh its epidemiological benefit. Under higher budget conditions, resolution of epidemiological uncertainty is most valuable. When budgets are tight, however, operational and epidemiological uncertainty are equally important. Overall, our study demonstrates that significant public health improvements could result from a careful examination of both epidemiological and operational uncertainties within the same modelling structure. This approach can be applied to decision-making for management of other diseases for which multiple models and multiple interventions are available.

Proceedings of the Royal Society B↗